LungLife AI, INC Publication of Annual Report & Notice of AGM (6835V)
April 06 2023 - 10:50AM
UK Regulatory
TIDMLLAI
RNS Number : 6835V
LungLife AI, INC
06 April 2023
LungLife AI, Inc.
(the "Company" or "LungLife")
Publication of Annual Report and Accounts & Notice of
AGM
LungLife AI (AIM: LLAI), a developer of clinical diagnostic
solutions for lung cancer, announces that the Annual Report and
Accounts, Notice of Annual General Meeting ("AGM"), Form of
Direction and associated Form of Proxy are now available on the
Company's website and have been posted to those shareholders who
have opted out of electronic communications .
The documents are available here:
https://investors.lunglifeai.com/
The Company's AGM will be held at 3:00 P.M. (BST) on 4 May 2023,
at Investec Bank plc, 30 Gresham Street, London, EC2V 7QP. The
Board will make arrangements for shareholders to listen to
proceedings remotely should they wish to do so. The Company will
announce details of how to listen to the meeting remotely and any
other significant changes to the meeting arrangements via RNS and
on LungLife's website at https://investors.lunglifeai.com/
Shareholders are strongly encouraged to vote by proxy, whether
or not they plan to attend the Company's AGM in person.
Shareholders may register their votes on the resolutions of the AGM
by completing and returning the Form of Proxy that accompanies the
Notice of AGM in accordance with the instructions printed on the
Form of Proxy.
Where shareholders hold Common Shares by way of dematerialised
depository interests representing underlying Common Shares
("Depository Interests"), they can vote through the CREST system or
by returning a Form of Direction to the Company's agent, Link
Group. Further instructions are set out in the Notes to the Notice
of AGM.
The resolutions to be proposed at the AGM are summarised in the
Notice of AGM.
The results of voting on the resolutions will be announced via a
regulatory information service and posted on the Company's website
as soon as practicable possible after the AGM.
For further information please contact:
LungLife AI, Inc. www.lunglifeai.com
Paul Pagano, CEO Via Walbrook PR
David Anderson, CFO
Investec Bank plc (Nominated Adviser Tel: +44 (0)20 7597 5970
& J oint Broker)
Virginia Bull / Cameron MacRitchie
/ Lydia Zychowska
Goodbody (Joint Broker) Tel: +44 (0) 20 3841 6202 / +353 (1)
Tom Nicholson / Stephen Kane 667 0420
Walbrook PR Limited Tel: +44 (0)20 7933 8780 or LungLifeAI@walbrookpr.com
Stephanie Cuthbert / Alice Woodings Mob: 07980 541 893 / 07407 804 654 /
/ Phillip Marriage 07867 984 082
About LungLife
LungLife AI is a developer of clinical diagnostic solutions
designed to make a significant impact in the early detection of
lung cancer, the deadliest cancer globally. Using a minimally
invasive blood draw, the Company's LungLB(R) test is designed to
deliver additional information to clinicians who are evaluating
indeterminate lung nodules. For more information visit
www.lunglifeai.com
Our Purpose is to be a driving force in the early detection to
lung cancer. Our Vision is to invert the 20:80 ratio such that in
years to come at least 80% of lung cancer is detected early.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOAIFMITMTIMBPJ
(END) Dow Jones Newswires
April 06, 2023 10:50 ET (14:50 GMT)
Lunglife Ai (LSE:LLAI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Lunglife Ai (LSE:LLAI)
Historical Stock Chart
From Oct 2023 to Oct 2024